NUPR1 and triple-negative breast carcinoma: Specifically, WTAP elevates Lipocalin 2 expression by enhancing nuclear protein 1 (NUPR1) m6A methylation, thereby repressing ferroptosis and facilitating triple-negative breast cancer progression [169].